Bank of New York Mellon’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,645
| Closed | -$25K | – | 4606 |
|
|
2022
Q2 | $25K | Sell |
2,645
-16,387
| -86% | -$155K | ﹤0.01% | 4471 |
|
|
2022
Q1 | $227K | Sell |
19,032
-373
| -2% | -$4.45K | ﹤0.01% | 4174 |
|
|
2021
Q4 | $633K | Sell |
19,405
-210
| -1% | -$6.85K | ﹤0.01% | 3647 |
|
|
2021
Q3 | $876K | Buy |
19,615
+930
| +5% | +$41.5K | ﹤0.01% | 3464 |
|
|
2021
Q2 | $1.02M | Buy |
18,685
+3,949
| +27% | +$215K | ﹤0.01% | 3409 |
|
|
2021
Q1 | $1.1M | Buy |
14,736
+1,122
| +8% | +$83.9K | ﹤0.01% | 3273 |
|
|
2020
Q4 | $1.48M | Sell |
13,614
-795
| -6% | -$86.3K | ﹤0.01% | 3020 |
|
|
2020
Q3 | $1.27M | Sell |
14,409
-496
| -3% | -$43.8K | ﹤0.01% | 2972 |
|
|
2020
Q2 | $1.59M | Buy |
14,905
+3,229
| +28% | +$344K | ﹤0.01% | 2813 |
|
|
2020
Q1 | $692K | Buy |
11,676
+540
| +5% | +$32K | ﹤0.01% | 3212 |
|
|
2019
Q4 | $770K | Sell |
11,136
-11
| -0.1% | -$761 | ﹤0.01% | 3362 |
|
|
2019
Q3 | $1.16M | Buy |
11,147
+556
| +5% | +$57.7K | ﹤0.01% | 3079 |
|
|
2019
Q2 | $981K | Buy |
10,591
+2,266
| +27% | +$210K | ﹤0.01% | 3222 |
|
|
2019
Q1 | $761K | Sell |
8,325
-129
| -2% | -$11.8K | ﹤0.01% | 3336 |
|
|
2018
Q4 | $470K | Buy |
8,454
+689
| +9% | +$38.3K | ﹤0.01% | 3515 |
|
|
2018
Q3 | $925K | Buy |
7,765
+706
| +10% | +$84.1K | ﹤0.01% | 3308 |
|
|
2018
Q2 | $720K | Buy |
7,059
+1,900
| +37% | +$194K | ﹤0.01% | 3430 |
|
|
2018
Q1 | $670K | Buy |
5,159
+1,637
| +46% | +$213K | ﹤0.01% | 3428 |
|
|
2017
Q4 | $343K | Sell |
3,522
-11
| -0.3% | -$1.07K | ﹤0.01% | 3749 |
|
|
2017
Q3 | $520K | Buy |
3,533
+531
| +18% | +$78.2K | ﹤0.01% | 3571 |
|
|
2017
Q2 | $483K | Buy |
3,002
+1,838
| +158% | +$296K | ﹤0.01% | 3616 |
|
|
2017
Q1 | $185K | Buy |
+1,164
| New | +$185K | ﹤0.01% | 3896 |
|